Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DNTOX GmbH is a neurotoxicity testing service provider based in Düsseldorf, Germany, positioning itself as a “next-generation neurotoxicity testing” partner. Its core offering is not SaaS or enterprise software in the traditional sense, but animal-free, in vitro 2D and 3D testing systems and toxicology testing services for industries such as chemicals, pharmaceuticals, and cosmetics, with a focus on human-relevant nervous system models.
Based on the site content, DNTOX’s main capabilities are centered on developmental neurotoxicity and adult neurotoxicity assessment. Its testing covers key processes such as neural progenitor cell proliferation, neuronal migration and differentiation, neurite outgrowth, neural network formation and function, general cytotoxicity, and cell viability. The company also provides acute toxicity screening, Bulk RNA sequencing-based transcriptomic analysis, biostatistics, bioinformatics, as well as model development and custom assay development. Its approach emphasizes human-derived, multicellular, multiplex 2D/3D in vitro systems and notes alignment with the direction of OECD Initial Recommendations No. 377.
The website does not disclose any packages, pricing, billing models, free trials, or standard delivery timelines. Given the nature of the services, projects are likely quoted based on the specific tests, study scope, or customized plans, but this is not explicitly stated in the content and should not be treated as confirmed information. Payment methods are also not disclosed.
Its strength lies in a clear technical direction: replacing traditional animal testing with animal-free, human-relevant in vitro models, making it suitable for safety assessment scenarios that require stronger human relevance and reduced reliance on animal experiments. It also has bioinformatics and transcriptomic analysis capabilities, supporting deeper mechanistic research. The limitation is that information from an enterprise software perspective is almost entirely absent: there is no visible mention of a customer portal, collaboration permissions, APIs, third-party integrations, cloud deployment, or self-hosting options. Data security certifications, privacy compliance, and sample/data handling workflows are also not disclosed.
DNTOX is better suited for pharmaceutical companies, chemical companies, cosmetics companies, research institutions, and regulatory-related project teams that need neurotoxicity screening, compound prioritization, hazard identification, and regulatory-oriented decision support. It is not suitable for users looking for a standardized SaaS platform, an online experimental data management system, or self-service subscription software.
The content does not provide information specific to the Chinese market, and it is not possible to determine from the text whether the website is stable to access from mainland China. Therefore, its China access status is marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on dntox.de official site.
dntox.de is an Germany Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach dntox.de directly.